Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Titan Pharmaceuticals Inc (Titan Pharmaceuticals), a subsidiary of Black Titan Corp, is a development-stage biotechnology company that develops proprietary therapeutics for the treatment of chronic conditions. The company's lead product, Probuphine which targets opioid use disorder. Its proprietary ProNeura long-term drug delivery platform has the potential to be used in developing products for treating several chronic conditions were maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes. The company operates the US, Canada, and the European Union. Titan Pharmaceuticals is headquartered in New York, the US.
Products and Services
| Products | Brands |
|---|---|
| Probuphine: Opioid Use Disorder | Proneura |
| Technology Platform: | Probuphine |
| ProNeura Platform |
Competitor Comparison
| Key Parameters | Titan Pharmaceuticals Inc | Alimera Sciences Inc | MediciNova Inc | RegeneRx Biopharmaceuticals Inc |
|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America |
| City | New York | Alpharetta | La Jolla | Rockville |
| State/Province | New York | Georgia | California | Maryland |
| No. of Employees | 4 | 159 | 6 | 2 |
| Entity Type | Private | Private | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Chay Weei Jye | Secretary; Director | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer